Trial Site Detail
Drug: |
PLX9486 + PLX3397 |
|||
|---|---|---|---|---|
Trial: |
PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Dana Farber Cancer Institute450 Brookline Ave |
Principal Investigator: |
Andrew Wagner, MD, PhD |
|---|---|
Contact: |
Melissa Hohos, mhohos@partners.org Mark Morley, mmorley@partners.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Dana Farber Cancer Institute Website: |
http://www.dana-farber.org/Research/Clinical-Trials.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.